Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
6 hedge funds and large institutions have $632K invested in Counterpath Corp in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
14% less funds holding
Funds holding: 7 → 6 (-1)
18% less capital invested
Capital invested by funds: $769K → $632K (-$137K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$675 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$18 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $605K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $21K | – | – | – |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2K | +$675 | +300 | +38% |
|
|
5
Morgan Stanley
New York
| – | -$18 | -8 | -14% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| – | +$427 | +190 | New |
|
CPAH Hedge Fund Activity: Q2 2016 in Review
6 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q2 2016, worth a combined $632K — down 18% from $769K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CPAH and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $675. The largest seller was Morgan Stanley, cutting an estimated $18.
- 6 institutional investors held Counterpath Corp (CPAH) as of Q2 2016, down from 7 in Q1 2016.
- Funds reported $632K of Counterpath Corp stock for Q2 2016, down 18% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q2 2016 and 2 closed out, a net change of -1 holder.
- The largest Counterpath Corp buyer in Q2 2016 was Tower Research Capital (TRC), an estimated $675 added.
- The largest Counterpath Corp seller in Q2 2016 was Morgan Stanley, an estimated $18 sold.
Based on aggregated 13F filings for Q2 2016.